UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Differences in activities and substrate specificity of human and murine pyrimidine nucleoside phosphorylases : implications for chemotherapy with 5-fluoropyrimidines

Cancer research (Chicago, Ill.), 1993-08, Vol.53 (16), p.3687-3693

1993

Volltextzugriff (PDF)

O.1.2 - EVALUATION OF PATIENT POSITIONING BETWEEN SURFACE-GUIDED RADIOTHERAPY AND THREE-POINT MARKERS

Physica medica, 2022-12, Vol.104, p.S7-S7

2022

Volltextzugriff (PDF)

EVALUATION OF PATIENT POSITIONING BETWEEN SURFACE-GUIDED RADIOTHERAPY AND THREE-POINT MARKERS

Physica medica, 2022-12, Vol.104, p.S7

2022

Volltextzugriff (PDF)

Metabolism and Selective Toxicity of 6-Nitrobenzylthioinosine in Toxoplasma gondii

Antimicrobial Agents and Chemotherapy, 1999-10, Vol.43 (10), p.2437-2443

1999

Volltextzugriff (PDF)

Intracellular Metabolism of β-l-2′,3′-Dideoxyadenosine: Relevance to Its Limited Antiviral Activity

Antimicrobial Agents and Chemotherapy, 2000-04, Vol.44 (4), p.853-858

2000

Volltextzugriff (PDF)

Pyrimidine nucleobase ligands of orotate phosphoribosyltransferase from toxoplasma gondii

Biochemical pharmacology, 1999-11, Vol.58 (9), p.1457-1466

1999

Volltextzugriff (PDF)

Uridine phosphorylase inhibitors: Chemical modification of benzyloxybenzyl-barbituric acid and its effects on UrdPase inhibition

Bioorganic & medicinal chemistry letters, 1999-06, Vol.9 (11), p.1477-1480

1999

Volltextzugriff (PDF)

The adenosine transporter of Toxoplasma gondii. Identification by insertional mutagenesis, cloning, and recombinant expression

The Journal of biological chemistry, 1999-12, Vol.274 (49), p.35255-35261

1999

Volltextzugriff (PDF)

Structure-activity relationship for the binding of nucleoside ligands to adenosine kinase from Toxoplasma gondii

Biochemical pharmacology, 1995-05, Vol.49 (10), p.1501-1512

1995

Volltextzugriff (PDF)

5-phenylthioacyclouridine: a potent and specific inhibitor of uridine phosphorylase

Biochemical pharmacology, 2000-09, Vol.60 (6), p.851-856

2000

Volltextzugriff (PDF)

Potential chemotherapeutic targets in the purine metabolism of parasites

Pharmacology & therapeutics (Oxford), 2003-09, Vol.99 (3), p.283-309

el Kouni, Mahmoud H

2003

Volltextzugriff (PDF)

Modulation of 5-fluorouracil host toxicity by 5-(benzyloxybenzyl)barbituric acid acyclonucleoside, a uridine phosphorylase inhibitor, and 2′,3′,5′-tri- O-acetyluridine, a prodrug of uridine

Biochemical pharmacology, 2000-08, Vol.60 (3), p.427-431

2000

Volltextzugriff (PDF)

Enzymes of uracil catabolism in normal and neoplastic human tissues

Cancer research (Chicago, Ill.), 1985-11, Vol.45 (11), p.5405-5412

1985

Volltextzugriff (PDF)

Structure-activity relationships for the binding of ligands to xanthine or guanine phosphoribosyl-transferase from Toxoplasma gondii

Biochemical pharmacology, 1995-11, Vol.50 (10), p.1685-1693

1995

Volltextzugriff (PDF)

Effect of administration of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on the anti-tumor efficacy of 5-fluoro-2′-deoxyuridine against murine colon tumor C26–10

Biochemical pharmacology, 2000-09, Vol.60 (5), p.687-692

2000

Volltextzugriff (PDF)

Modulation of the pharmacokinetics of endogenous plasma uridine by 5-(phenylthio)acyclouridine, a uridine phosphorylase inhibitor: implications for chemotherapy

Cancer chemotherapy and pharmacology, 2001-08, Vol.48 (2), p.145-150

2001

Volltextzugriff (PDF)

Insertional tagging of at least two loci associated with resistance to adenine arabinoside in Toxoplasma gondii, and cloning of the adenosine kinase locus

Molecular and biochemical parasitology, 1999-09, Vol.103 (1), p.1-14

1999

Volltextzugriff (PDF)

Modulation of plasma uridine concentration by 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase : relevance to chemotherapy

Cancer chemotherapy and pharmacology, 2000, Vol.45 (5), p.351-361

2000

Volltextzugriff (PDF)

Effects of modifications in the pentose moiety and conformational changes on the binding of nucleoside ligands to uridine phosphorylase from Toxoplasma gondii

Biochemical pharmacology, 1996-06, Vol.51 (12), p.1687-1700

1996

Volltextzugriff (PDF)

Effect of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on plasma concentration of uridine released from 2', 3', 5'-tri-O-acetyluridine, a prodrug of uridine: relevance to uridine rescue in chemotherapy

Cancer chemotherapy and pharmacology, 2000, Vol.46 (3), p.235-240

2000

Volltextzugriff (PDF)

Enhancement of 5-fluoro-2'-deoxyuridine antitumor efficacy by the uridine phosphorylase inhibitor 5-(benzyloxybenzyl)barbituric acid acyclonucleoside

Cancer research (Chicago, Ill.), 1995-03, Vol.55 (5), p.1092-1098

1995

Volltextzugriff (PDF)

Phenylselenenyl- and phenylthio-substituted pyrimidines as inhibitors of dihydrouracil dehydrogenase and uridine phosphorylase

Journal of medicinal chemistry, 1993-12, Vol.36 (26), p.4250-4254

1993

Volltextzugriff (PDF)

Structure-activity relationships for the binding of ligands to xanthine or guanine phosphoribosyltransferase from Toxoplasma gondii

Biochemical pharmacology, 1995-01, Vol.50 (10), p.1685-1693

1995

Volltextzugriff (PDF)

Determinants for Genital Human Papillomavirus (HPV) Infection in Tunisian Women with Normal Pap smear: Are There Different Risk Profiles for Oncogenic and Nononcogenic HPV Types?

IProceedings, 2018-03, Vol.4 (1), p.e10590

2018

Volltextzugriff (PDF)

Kinetic studies of thymidine phosphorylase from mouse liver

Biochemistry (Easton), 1985-11, Vol.24 (24), p.6799-6807

1985

Volltextzugriff (PDF)

1 – 25 von 142

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(126)
Mit Volltextzugriff
(129)

Publikationsform

Artikel
(141)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(97)
Life Sciences & Biomedicine
(95)
Animals
(65)
Biological And Medical Sciences
(57)
Humans
(53)
Pharmacology & Pharmacy
(51)
Medical Sciences
(49)
Pharmacology. Drug Treatments
(43)
Mice
(40)
Female
(37)
Chemotherapy
(23)
Male
(23)
Uridine Phosphorylase - Antagonists & Inhibitors
(22)
Structure-Activity Relationship
(19)
Uracil - Analogs & Derivatives
(19)
Antineoplastic Agents
(18)
Biochemistry & Molecular Biology
(16)
Kinetics
(16)
Oncology
(16)
Thioinosine - Analogs & Derivatives
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Differences in activities and substrate specificity of human and murine pyrimidine nucleoside phosphorylases : implications for chemotherapy with 5-fluoropyrimidines

O.1.2 - EVALUATION OF PATIENT POSITIONING BETWEEN SURFACE-GUIDED RADIOTHERAPY AND THREE-POINT MARKERS

EVALUATION OF PATIENT POSITIONING BETWEEN SURFACE-GUIDED RADIOTHERAPY AND THREE-POINT MARKERS

Metabolism and Selective Toxicity of 6-Nitrobenzylthioinosine in Toxoplasma gondii

Intracellular Metabolism of β-l-2′,3′-Dideoxyadenosine: Relevance to Its Limited Antiviral Activity

Pyrimidine nucleobase ligands of orotate phosphoribosyltransferase from toxoplasma gondii

Uridine phosphorylase inhibitors: Chemical modification of benzyloxybenzyl-barbituric acid and its effects on UrdPase inhibition

The adenosine transporter of Toxoplasma gondii. Identification by insertional mutagenesis, cloning, and recombinant expression

Structure-activity relationship for the binding of nucleoside ligands to adenosine kinase from Toxoplasma gondii

5-phenylthioacyclouridine: a potent and specific inhibitor of uridine phosphorylase

Potential chemotherapeutic targets in the purine metabolism of parasites

Modulation of 5-fluorouracil host toxicity by 5-(benzyloxybenzyl)barbituric acid acyclonucleoside, a uridine phosphorylase inhibitor, and 2′,3′,5′-tri- O-acetyluridine, a prodrug of uridine

Enzymes of uracil catabolism in normal and neoplastic human tissues

Structure-activity relationships for the binding of ligands to xanthine or guanine phosphoribosyl-transferase from Toxoplasma gondii

Effect of administration of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on the anti-tumor efficacy of 5-fluoro-2′-deoxyuridine against murine colon tumor C26–10

Modulation of the pharmacokinetics of endogenous plasma uridine by 5-(phenylthio)acyclouridine, a uridine phosphorylase inhibitor: implications for chemotherapy

Insertional tagging of at least two loci associated with resistance to adenine arabinoside in Toxoplasma gondii, and cloning of the adenosine kinase locus

Modulation of plasma uridine concentration by 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase : relevance to chemotherapy

Effects of modifications in the pentose moiety and conformational changes on the binding of nucleoside ligands to uridine phosphorylase from Toxoplasma gondii

Effect of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on plasma concentration of uridine released from 2', 3', 5'-tri-O-acetyluridine, a prodrug of uridine: relevance to uridine rescue in chemotherapy

Enhancement of 5-fluoro-2'-deoxyuridine antitumor efficacy by the uridine phosphorylase inhibitor 5-(benzyloxybenzyl)barbituric acid acyclonucleoside

Phenylselenenyl- and phenylthio-substituted pyrimidines as inhibitors of dihydrouracil dehydrogenase and uridine phosphorylase

Structure-activity relationships for the binding of ligands to xanthine or guanine phosphoribosyltransferase from Toxoplasma gondii

Determinants for Genital Human Papillomavirus (HPV) Infection in Tunisian Women with Normal Pap smear: Are There Different Risk Profiles for Oncogenic and Nononcogenic HPV Types?

Kinetic studies of thymidine phosphorylase from mouse liver

Suchergebnisse filtern